The calm after the storm: How COVID-19 is making pharma more resilientCOVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products. But learning Share XThe calm after the storm: How COVID-19 is making pharma more resilienthttps://pharmaphorum.com/views-analysis-sales-marketing/the-calm-after-the-storm-how-covid19-is-making-pharma-more-resilient-and-accessible/
Vertex Pharma’s vision for reimbursement innovationAs regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s Share XVertex Pharma’s vision for reimbursement innovationhttps://pharmaphorum.com/views-analysis-market-access/vertex-pharmas-vision-for-reimbursement-innovation/
Alnylam’s Anant Murthy on making it as a US biotech in EuropeAlnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how Share XAlnylam’s Anant Murthy on making it as a US biotech in Europehttps://pharmaphorum.com/r-d/views-analysis-r-d/alnylam-anant-murthy-on-making-it-as-a-us-biotech-in-europe/
When healthcare met digital health: the next chapter of pharmaphorumBack in 2009, when I was living in Windsor, I remember walking to the pub with my wife Share XWhen healthcare met digital health: the next chapter of pharmaphorumhttps://pharmaphorum.com/views-analysis-digital/when-healthcare-met-digital-health-the-next-chapter-of-pharmaphorum/
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisisCOVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic. Share XJanssen’s Gaëtan Leblay on leading during the COVID-19 crisishttps://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/
Has COVID-19 forever changed the way pharma does business?There’s no doubt that the COVID-19 pandemic has thrust digital engagement into the spotlight for the pharmaceutical industry Share XHas COVID-19 forever changed the way pharma does business?https://pharmaphorum.com/views-and-analysis/has-covid-19-forever-changed-the-way-pharma-does-business/
AstraZeneca: pharma needs to lead by example on sustainabilityPaul Tunnah sat down with AstraZeneca’s vice president of sustainability strategy and engagement Jim Massey to discuss how Share XAstraZeneca: pharma needs to lead by example on sustainabilityhttps://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-pharma-needs-to-lead-by-example-on-sustainability/
Engaging with customers in a digital worldAs part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains Share XEngaging with customers in a digital worldhttps://pharmaphorum.com/views-analysis-digital/engaging-with-customers-in-a-digital-world/
Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticsPaul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk Share XSanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticshttps://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/
